Search
Search Results
-
Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette–Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis
PurposeTo compare adjuvant hyperthermic intravesical chemotherapy (HIVEC) with mitomycin C and standard Bacillus Calmette–Guerin (BCG) therapy in...
-
Device-assisted intravesical chemotherapy versus bacillus Calmette–Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis
PurposeTo investigate the effectiveness and safety of device-assisted intravesical chemotherapy compared to Bacillus Calmette–Guerin (BCG) in the...
-
Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507)
The South West Oncology Group’s 2000 randomised-control trial investigated the addition of maintenance intravesical bacillus Calmette-Guerin (BCG) to...
-
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
ObjectivesThe treatments for high-grade non-muscle invasive bladder cancer (NMIBC) vary between bladder preserving intravesical approaches and...
-
Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy
PurposeWe investigated sleep parameters and patient-reported outcomes before, during, and after induction Bacillus Calmette-Guerin therapy using...
-
Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment–induced sleep quality deterioration in patients with non-muscle invasive bladder cancer
PurposeThe level of 6-sulfatoxy-melatonin (SaMT), a metabolite of melatonin, in first-void morning urine reflects blood melatonin levels from the...
-
Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-Analysis
BackgroundThe BCG vaccine has been traditionally administered to prevent TB. It has been additionally used in bladder cancer patients as a therapy...
-
Reactive Arthritis following Bacillus Calmette–Guerin Therapy for Bladder Cancer: a Systematic Literature Review
Purpose of ReviewIntravesical BCG therapy (ivBCG) is a treatment for bladder cancer that complements surgery and prevents tumor progression. Reactive...
-
Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
Intravesical BCG therapy is an integral part of management of non-muscle invasive bladder cancers. Our aim is to analyze the non-muscle invasive...
-
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
BackgroundThe optimal surveillance method for recurrence of non-muscle invasive bladder cancer (NMIBC) after intravesical BCG treatment is unknown....
-
Bacillus Calmette Guerin (BCG) Balanitis: a Rare Organ Complication of Non-muscle Invasive Urinary Bladder Cancer Following Intravesical Immunotherapy
Bacillus Calmette Guerin (BCG) is widely used for prevention of recurrence and progression in non-muscle invasive urinary bladder cancers. However,...
-
Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study
BackgroundIntravesical bacillus Calmette-Guerin (BCG) therapy is the treatment of choice for patients with T1 or high-grade superficial bladder...
-
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
PurposeTo determine the need for routine bladder biopsies (BBs) in assessing response to the induction cycle of intravesical bacillus Calmette–Guérin...
-
Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report
BackgroundJoint replacement is an effective intervention and prosthetic joint infection (PJI) is one of the most serious complications of such...
-
Post-Bacillus Calmette-Guérin Cystitis: A Systematic Review of the Literature
Purpose of ReviewIntravesical Bacillus Calmette-Guérin (BCG) is used as adjuvant therapy for intermediate-risk and high-risk non-muscle invasive...
-
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin
PurposeTo determine the impact of time to restaging transurethral resection (Re-TUR) on recurrence-free survival (RFS), progression-free survival...
-
Effects and Complications of Intravesical Instillation of Bacillus Calmette-Guerin Therapy
Purpose of ReviewThis review will address the current literature available regarding complications after intravesical Bacillus Calmette-Guerin (BCG)...
-
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
Therapeutic repurposing emerged as an alternative to the traditional drug discovery and development model (DDD) of new molecular entities (NMEs). It...